Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children

AIM: To investigate the safety and efficacy of a Hansenula-derived PEGylated (polyethylene glycol) interferon (IFN)-alpha-2a (Reiferon Retard) plus ribavirin customized regimen in treatment-naïve and previously treated (non-responders and relapsers) Egyptian children with chronic hepatitis C infecti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: El Naghi, Suzan, Abdel-Ghaffar, Tawhida Y, El-Karaksy, Hanaa, Abdel-Aty, Elham F, El-Raziky, Mona S, Allam, Aleef A, Helmy, Heba, El-Araby, Hanaa A, Behairy, Behairy E, El-Guindi, Mohamed A, El-Sebaie, Hatem, Abdel-Ghaffar, Aisha Y, Ehsan, Nermin A, El-Hennawy, Ahmed M, Sira, Mostafa M
Format: Artigo
Sprache:Inglês
Veröffentlicht: Baishideng Publishing Group Co., Limited 2014
Schlagworte:
Brief Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4000504/
https://ncbi.nlm.nih.gov/pubmed/24782620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i16.4681
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge